These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1939435)

  • 1. Separation and quantitation of serum proinsulin and proinsulin intermediates in humans.
    Linde S; Røder ME; Hartling SG; Binder C; Welinder BS
    J Chromatogr; 1991 Jul; 548(1-2):371-80. PubMed ID: 1939435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
    Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
    Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
    J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography.
    Linde S; Welinder BS; Nielsen JH
    J Chromatogr; 1993 May; 614(2):185-204. PubMed ID: 8314931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients.
    Robbins DC; Shoelson SE; Tager HS; Mead PM; Gaynor DH
    Diabetes; 1985 May; 34(5):510-9. PubMed ID: 3886464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of des(64,65)-human proinsulin in the rat. Evidence for the proteolytic processing to insulin.
    Wroblewski VJ; Masnyk M; Kaiser RE
    Diabetes; 1993 Oct; 42(10):1407-14. PubMed ID: 8375581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography.
    Knip M
    Horm Metab Res; 1984 Sep; 16(9):487-91. PubMed ID: 6149991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus.
    Gadot M; Leibowitz G; Shafrir E; Cerasi E; Gross DJ; Kaiser N
    Endocrinology; 1994 Aug; 135(2):610-6. PubMed ID: 8033810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.
    Seino S; Funakoshi A; Fu ZZ; Vinik A
    Diabetes; 1985 Jan; 34(1):1-7. PubMed ID: 3880547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-ideal behaviour of silica-based stationary phases in trifluoroacetic acid-acetonitrile-based reversed-phase high-performance liquid chromatographic separations of insulins and proinsulins.
    Linde S; Welinder BS
    J Chromatogr; 1991 Jan; 536(1-2):43-55. PubMed ID: 1646830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative hypersecretion of proinsulin in rat model of NIDDM.
    Leahy JL; Halban PA; Weir GC
    Diabetes; 1991 Aug; 40(8):985-9. PubMed ID: 1860563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human insulin. V. Optimization of the reversed-phase high-performance liquid chromatographic separation.
    Klyushnichenko VE; Yakimov SA; Arutyunyan AM; Ivanov AE; Maltsev KV; Wulfson AN
    J Chromatogr B Biomed Appl; 1994 Dec; 662(2):363-9. PubMed ID: 7719491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinative interactions in the separation of insulin and its derivatives by high-performance liquid chromatography.
    Péter A; Szepesi G; Baláspiri L; Burger K
    J Chromatogr; 1987 Nov; 408():43-52. PubMed ID: 3323216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.
    Ostrega D; Polonsky K; Nagi D; Yudkin J; Cox LJ; Clark PM; Hales CN
    Diabetes; 1995 Apr; 44(4):437-40. PubMed ID: 7698513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proinsulin. Comparison of insulin specific protease and gel filtration assays.
    Cresto JC; Lavine RL; Fink G; Recant L
    Diabetes; 1974 Jun; 23(6):505-11. PubMed ID: 4365950
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating proinsulin-like component in man: increased proportion in hypoinsulinemic states.
    Gorden P; Hendricks CM; Roth J
    Diabetologia; 1974 Oct; 10(5):469-74. PubMed ID: 4452432
    [No Abstract]   [Full Text] [Related]  

  • 20. A direct two-site peroxidase-based enzyme-linked immunosorbent assay for proinsulin.
    Doyle V; Devery R
    J Pharm Biomed Anal; 1994 Sep; 12(9):1079-82. PubMed ID: 7803555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.